Craniomaxillofacial Devices Market Size, Share & Trends Analysis Report By Material (Metal, Ceramics), By Product (CMF Plate & Screw Fixation, Bone Graft Substitute), By Application, And Segment Forecasts, 2021 - 2028

Report Overview

The global craniomaxillofacial devices market size was valued at USD 1.6 billion in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 9.0% over the forecast period. High preference for minimally invasive surgeries owing to the availability of technologically advanced products is one of the key factors expected to support market growth. For instance, a leading company, Zimmer Biomet, offers ROSA ONE Brain, a robotic platform that helps in performing minimally invasive complex neurosurgical procedures. Rising cases of facial and head injuries caused due to sports-related injuries are also expected to boost the demand for craniomaxillofacial (CMF) devices.

According to a 2018 report by the Centers for Disease Control and Prevention (CDC), an estimated 1.7 to 3.8 million traumatic brain injuries are reported each year in the U.S., 10% of which arise due to sports and recreational activities. Furthermore, the U.S. Consumer Product Safety Commission (CPSC) data stated that in 2018 there were approximately 454,407 sports-related head injuries treated at the U.S. hospital emergency rooms.

This highlights the high growth prospects for the CMF device manufacturers in the country. Rising incidents of road accidents are also expected to increase the demand for CMF devices. According to Columbia University (Department of Neurology), motor vehicle accidents are one of the most common causes of Traumatic Brain Injuries (TBIs) among children and adults in the U.S.

On a global note as well, a rise in the number of road accidents is expected to boost product demand, especially from developing countries. However, there has been cancellation and rescheduling of surgical procedures due to the global pandemic, which may have a negative impact on market growth.

Product Insights

The CMF plate and screw fixation segment held the largest market share of over 73% in 2020. The segment will retain its dominant position due to the wide usage of these products in various surgical procedures, such as deformity correction, orthognathic surgery, tumor removal, and pediatric surgeries. Bone Graft Substitute (BGS), on the other hand, is projected to be the fastest-growing product segment during the forecast period. Bone graft substitutes are used in the reconstruction of bone defects and in the case of spine fusion.

Limited availability of donors has led to a shortage of natural bone grafts creating demand for bone graft substitutes. Some of the popularly used synthetic bone substitutes include calcium sulfate, calcium phosphate ceramics, and bioactive glass-ceramics. France-based Biomatlante offers MBCP biphasic calcium phosphate synthetic BGS. It closely resembles the architecture of natural human bone and gradually dissolves in the body, promoting new bone formation through the release of calcium and phosphate ions.

Material Insights

The metallic implants segment led the overall market in 2020 with a share of over 70% and will expand further at a steady CAGR from 2021 to 2028. This growth is credited to the high demand for metallic implants as they have high corrosion resistance, can provide rigid support to the fractures, and are cheaper than bioabsorbable counterparts.

Titanium and its alloy are the most commonly used metals for CMF surgery due to the advantage associated with it, such as lightweight, inert metallic property, the strength provided to implants, high tissue acceptance, and corrosion resistance. It is used in mandibular reconstruction.

Bioabsorbable materials are projected to be the fastest-growing material segment during the forecast period as the usage of these implants nullifies the chances of a second surgery. Technological advancements in CMF surgery, for example, self-enforced technology and advantages associated with it, such as biocompatibility and reliability, are expected to propel the segment growth.

Application Insights

The orthognathic & dental surgery segment held the largest revenue share of over 54% in 2020 owing to wide product usage to correct a variety of minor and major skeletal and dental deformities. Neurosurgery & ENT is estimated to be the fastest-growing segment owing to the increasing incidence of trauma and spinal disorders requiring Cerebrospinal Fluid (CSF) management during surgery. Surgeons perform craniotomies to gain greater access to the brain during neurosurgery. Craniotomies are done to treat trauma, infection in the brain, skull fractures, aneurysm, epilepsy, and Parkinson’s disease. Moreover, the adoption of deep brain stimulation procedures is one of the key contributing factors for this segment's growth.

In deep brain stimulation, the implants are used to cover the skull after inserting the electrode. Neurosurgical application of cranial implants consists of surgery of skull and otolaryngology procedures. These devices assist in treating neuro-oncology, neurovascular diseases, spinal disorders, dura mater repair, transnasal skull-based surgery, deep brain stimulation, pelvic or cranial trauma, and CSF management. Medpor bioabsorbable implants are most commonly used for neurosurgery. Also, the introduction of surgical navigation technology for ENT procedures is expected to fuel market growth over the forecast period. Advantages associated with this technology, such as ease of use, 3D display, and real-time virtual anatomy updates, are anticipated to boost its adoption.

Regional Insights

North America led the global market in 2020 accounting for the largest revenue share of over 78% owing to the availability of technologically advanced implants and increased volume of CMF procedures. The region will expand further at a significant CAGR from 2021 to 2028 due to the factors, such as growing awareness about deformity correction surgeries and the presence of established healthcare facilities.

Apart from this, supportive government initiatives, such as the establishment of the American Society of Craniofacial Surgery (ASCFS), for creating awareness about CMF surgeries and associated advantages are likely to boost the demand for CMF devices in the region. Asia Pacific is estimated to be the fastest-growing regional market during the forecast period. The presence of untapped opportunities, constantly improving healthcare infrastructure, rapid economic development, and rising patient awareness are the key factors fueling the regional market growth.

Key Companies & Market Share Insights

The market is highly competitive and dominated by a limited number of companies, which have a strong footprint in the U.S. market owing to their extensive and advanced product offerings. New product launch and expansion are some of the key strategies adopted by these players to increase their market share. In 2017, DePuy Synthes, a subsidiary of Johnson & Johnson and a leading company in the market, launched the 3D-Printed titanium facial reconstruction implants.

However, the major market players are facing tough competition from small-scale medical device manufacturers that are involved in the development of technologically advanced products with greater efficiency. For instance, in January 2017, OSSDSIGN received the U.S. Food and Drug Administration (FDA) approval for its OSSDSIGN Cranial implants. Some of the prominent companies in the global craniomaxillofacial devices market include:

• DePuy Synthes (J&J)

• Stryker Corp.

• Medtronic plc

• Zimmer Biomet

Craniomaxillofacial Devices Market Report Scope

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2028. For the purpose of this study, Grand View Research has segmented the global craniomaxillofacial device market report on the basis of product, material, application, and region:

• Product Outlook (Revenue, USD Million, 2016 - 2028)

  • Cranial Flap Fixation

  • CMF Distraction

  • Temporomandibular Joint Replacement

  • Thoracic Fixation

  • Bone Graft Substitute

  • CMF Plate & Screw Fixation

• Material Outlook (Revenue, USD Million, 2016 - 2028)

  • Metal

  • Bioabsorbable Material

  • Ceramics

• Application Outlook (Revenue, USD Million, 2016 - 2028)

  • Neurosurgery & ENT

  • Orthognathic & Dental Surgery

  • Plastic Surgery

• Regional Outlook (Revenue, USD Million, 2016 - 2028)

  • North America

    • U.S.

    • Canada

  • Europe

    • U.K.

    • Germany

    • France

    • Italy

    • Spain

    • Russia

  • Asia Pacific

    • Japan

    • China

    • India

    • Australia

    • Singapore

    • Malaysia

  • Latin America

    • Brazil

    • Mexico

  • MEA

    • South Africa

    • Saudi Arabia